Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

609 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values.
Crawford ED, Leewansangtong S, Goktas S, Holthaus K, Baier M. Crawford ED, et al. Prostate. 1999 Mar 1;38(4):296-302. doi: 10.1002/(sici)1097-0045(19990301)38:4<296::aid-pros5>;2-p. Prostate. 1999. PMID: 10075009 Clinical Trial.
The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer.
Maccini MA, Westfall NJ, Van Bokhoven A, Lucia MS, Poage W, Maroni PD, Wilson SS, Glodé LM, Arangua P, Newmark J, Steiner M, Werahera PN, Crawford ED. Maccini MA, et al. Among authors: crawford ed. Prostate. 2018 May;78(7):506-511. doi: 10.1002/pros.23495. Epub 2018 Feb 19. Prostate. 2018. PMID: 29460452 Free PMC article.
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations.
Crawford ED, Heidenreich A, Lawrentschuk N, Tombal B, Pompeo ACL, Mendoza-Valdes A, Miller K, Debruyne FMJ, Klotz L. Crawford ED, et al. Prostate Cancer Prostatic Dis. 2019 Mar;22(1):24-38. doi: 10.1038/s41391-018-0079-0. Epub 2018 Aug 21. Prostate Cancer Prostatic Dis. 2019. PMID: 30131604 Free PMC article. Review.
Ten-year survival in patients with metastatic prostate cancer.
Tangen CM, Faulkner JR, Crawford ED, Thompson IM, Hirano D, Eisenberger M, Hussain M. Tangen CM, et al. Among authors: crawford ed. Clin Prostate Cancer. 2003 Jun;2(1):41-5. doi: 10.3816/cgc.2003.n.011. Clin Prostate Cancer. 2003. PMID: 15046683 Clinical Trial.
Prostate cancer. Introduction.
Crawford ED. Crawford ED. Urology. 2003 Dec 22;62(6 Suppl 1):1-2. doi: 10.1016/j.urology.2003.10.012. Urology. 2003. PMID: 14706502 No abstract available.
Combination of low-dose flutamide and finasteride for PSA-only recurrent prostate cancer after primary therapy.
Barqawi AB, Moul JW, Ziada A, Handel L, Crawford ED. Barqawi AB, et al. Among authors: crawford ed. Urology. 2003 Nov;62(5):872-6. doi: 10.1016/s0090-4295(03)00667-8. Urology. 2003. PMID: 14624911 Clinical Trial.
Recent advances in hormonal therapy for advanced prostate cancer.
Oottamasathien S, Crawford ED. Oottamasathien S, et al. Among authors: crawford ed. Oncology (Williston Park). 2003 Aug;17(8):1047-52; discussion 1054-8. Oncology (Williston Park). 2003. PMID: 12966672 Review.
The management of high risk prostate cancer.
Akduman B, Crawford ED. Akduman B, et al. Among authors: crawford ed. J Urol. 2003 Jun;169(6):1993-8. doi: 10.1097/01.ju.0000046241.95508.15. J Urol. 2003. PMID: 12771704 Review.
A 72-year-old man with prostate cancer.
Crawford ED. Crawford ED. Oncology (Williston Park). 2002 Aug;16(8):1014-6, 1119-21. Oncology (Williston Park). 2002. PMID: 12201642 No abstract available.
The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions.
Serkova NJ, Gamito EJ, Jones RH, O'Donnell C, Brown JL, Green S, Sullivan H, Hedlund T, Crawford ED. Serkova NJ, et al. Among authors: crawford ed. Prostate. 2008 May 1;68(6):620-8. doi: 10.1002/pros.20727. Prostate. 2008. PMID: 18213632
609 results
Jump to page